Global Personalized Medicine Bioinformatics Market Expected to Achieve 13.4% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Personalized Medicine Bioinformatics Market Size By 2025?
The market size for personalized medicine bioinformatics has seen a significant expansion in the last few years. Predictions indicate that it'll increase from $3.40 billion in 2024 and reach $3.87 billion by 2025, growing at a compound annual growth rate (CAGR) of 13.7%. Historical growth trends attribute this expansion to factors such as heightened usage of genomic sequencing technologies, surge in the demand for targeted therapeutic options, development in bioinformatics software solutions, broadening of the research and development initiatives in personalized medicine as well as regulatory backing for precision medicine ventures.

How Big Is the Personalized Medicine Bioinformatics Market Size Expected to Grow by 2029?
The market size of personalized medicine bioinformatics is projected to experience rapid expansion in the upcoming years, reaching $6.40 billion by 2029 with a compound annual growth rate (CAGR) of 13.4%. This growth for the period under forecast is likely due to the amalgamation of artificial intelligence and machine learning, a rising trend of using real-world data and predictive analytics, the broadening of cloud-based bioinformatics platforms, increased alliances between healthcare and tech firms, and a strengthened emphasis on patient-oriented treatment strategies. Some major trends expected during this forecast period include the creation of predictive analytics tools, innovative strides in multi-omics integration, the embracement of real-time patient monitoring systems, progress in genome editing technologies, and the rise of patient-centric healthcare models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-bioinformatics-global-market-report

Which Key Market Drivers Powering Personalized Medicine Bioinformatics Market Expansion and Growth?
The upswing in requirements for personalized medicine is anticipated to drive the expansion of the personalized medicine bioinformatics market in the future. Personalized medicine is a unique approach to prevention, diagnosis, and treatment developed according to each individual's exclusive genetic composition, health status, and lifestyle influences. The rise of personalized medicine can be attributed to progress in genomics and data analysis, which facilitate precise genetic profiling, leading to more targeted treatments with superior results and less guesswork. Personalized medicine bioinformatics employs genomic and clinical data to glean insights into individual health circumstances, assisting in accurate treatment selections and predictions of drug responses while guiding targeted therapies that improve customized patient care. For example, the Personalized Medicine Coalition, a hospital and health care organization based in the US, stated that in 2023, the FDA authorized 16 fresh personalized treatments for patients with rare diseases, up from six in 2022. Consequently, the rising demand for personalized medicine is propelling the expansion of the personalized medicine bioinformatics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28294&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Personalized Medicine Bioinformatics Market?
Key players in the personalized medicine bioinformatics market are zeroing in on creating advanced solutions like predictive analytics platforms to bolster disease prediction and boost patient outcomes. These platforms utilize machine learning, algorithms, and statistical models to scrutinize past and real-time data to forecast outcomes, equipping healthcare providers to foresee risks, fine-tune treatments, and formulate proactive decisions. For example, in April 2023, Certis Oncology Solutions, a biotech firm based in the US, unveiled CertisAI, a predictive analytics platform. This platform, powered by AI/ML, utilizes immense data, statistical algorithms, and machine learning to forecast drug efficacy based on gene expression biomarkers, with the goal of hastening drug discovery and the creation of companion diagnostics in precision oncology. The platform is authenticating its unique technique for predicting therapeutic response and backing its use as a service available to biopharmaceutical firms for improved early drug development choices and personalized cancer treatment strategies.

What Are the Emerging Segments in the Personalized Medicine Bioinformatics Market?
The personalized medicine bioinformatics market covered in this report is segmented as

1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, Other Technologies
2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals And Academic Medical Centers, Contact Research Organizations and Biobanks, Other End-Users

Subsegments:
1) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)
2) By Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction (ADR) Prediction, Biomarker Discovery, Personalized Drug Response Profiling
3) By Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization (CGH) Microarray
4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing (NLP) Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems (CDSS)
5) By Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28294&type=smp

Who Are the Global Leaders in the Personalized Medicine Bioinformatics Market?
Major companies operating in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.

Which are the Top Profitable Regional Markets for the Personalized Medicine Bioinformatics Industry?
North America was the largest region in the personalized medicine bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized medicine bioinformatics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28294

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.